Chr. Hansen - part of Novonesis
Clinical trials sponsored by Chr. Hansen - part of Novonesis, explained in plain language.
A bioscience company producing microbial solutions for food, health, and agriculture; now part of Novonesis.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a daily supplement soothe your gut and boost microbiome? Results expected Dec 2026 (estimated)